ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2021

Jan 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2021-01-01

Reporting Person: Hamilton James C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-01	Common Stock	A	50000	$0.00	Acquired	175000	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.